AU2016219650C1 — Compositions and methods for extended therapy with aminopyridines
Assigned to Acorda Therapeutics Inc · Expires 2018-08-23 · 8y expired
What this patent protects
) Disclosed herein are methods and compositions related to use of aminopyridines, such as 4 aminopyridine, for use in a therapeutically effective manner for patients with a demyelinating condition, such as multiple sclerosis.
USPTO Abstract
) Disclosed herein are methods and compositions related to use of aminopyridines, such as 4 aminopyridine, for use in a therapeutically effective manner for patients with a demyelinating condition, such as multiple sclerosis.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.